GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr | ₹4,869 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹991 Cr |
Mar2023 | ₹4,348 Cr |
Mar2022 | ₹3,670 Cr |
Mar2021 | ₹4,687 Cr |
Mar2020 | ₹4,869 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹991 Cr | -77.22 | |
Mar2023 | ₹4,348 Cr | 18.46 | |
Mar2022 | ₹3,670 Cr | -21.70 | |
Mar2021 | ₹4,687 Cr | -3.72 | |
Mar2020 | ₹4,869 Cr | - |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹39,503.8 Cr | -6.8% | -12% | 57.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,303.0 Cr | -5.1% | -9.4% | 29.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,389.0 Cr | -7.3% | -10.9% | 53% | Stock Analytics | |
CIPLA | ₹114,645.0 Cr | -1.4% | -6.7% | -1.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,449.5 Cr | -9% | -14.4% | 1.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,587.4 Cr | -7% | -5% | 22.6% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -6.8% |
-12% |
57.4% |
SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses